| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -22,1 k € | +98.4% | -1,4 M € | -517.4% | 331,2 k € | |
| EBITDA | -1,2 M € | +23.1% | -1,6 M € | -1346.0% | 128,1 k € | |
| Operating profit | -1,7 M € | +7.5% | -1,8 M € | -1906.9% | 99,8 k € | |
| Profit/loss | -1,8 M € | +7.1% | -1,9 M € | -3401.6% | 57,1 k € | |
| Equity | 834,8 k € | -67.7% | 2,6 M € | +4241.2% | 59,6 k € | |
| Total assets | 4,9 M € | +1.4% | 4,8 M € | +328.8% | 1,1 M € | |
| Cash | 433,9 k € | -66.8% | 1,3 M € | +1332.2% | 91,3 k € | |
| Debts | 4,1 M € | +80.8% | 2,2 M € | +110.5% | 1,1 M € | |
| Staff | 12,3 | 2,8 | 1 | |||
Private limited company · Genk · incorporated on 04/02/2022 · 12,3 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-66.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Swiftpharma is a Private limited company incorporated in 2022. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genk. It employs on average 12,3 ETP workers (FTE).